BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38336101)

  • 21. Hypoxia-induced acute lung injury in murine models of sickle cell disease.
    Pritchard KA; Ou J; Ou Z; Shi Y; Franciosi JP; Signorino P; Kaul S; Ackland-Berglund C; Witte K; Holzhauer S; Mohandas N; Guice KS; Oldham KT; Hillery CA
    Am J Physiol Lung Cell Mol Physiol; 2004 Apr; 286(4):L705-14. PubMed ID: 12972407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel hemoglobin-binding peptide reduces cell-free hemoglobin in murine hemolytic anemia.
    Hanson MS; Xu H; Flewelen TC; Holzhauer SL; Retherford D; Jones DW; Frei AC; Pritchard KA; Hillery CA; Hogg N; Wandersee NJ
    Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H328-36. PubMed ID: 23125208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A nonclinical safety and pharmacokinetic evaluation of N6022: a first-in-class S-nitrosoglutathione reductase inhibitor for the treatment of asthma.
    Colagiovanni DB; Drolet DW; Langlois-Forget E; Piché MP; Looker D; Rosenthal GJ
    Regul Toxicol Pharmacol; 2012 Feb; 62(1):115-24. PubMed ID: 22210450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of living at moderate altitude on pulmonary vascular function and exercise capacity in mice with sickle cell anaemia.
    Ferguson SK; Redinius K; Yalamanoglu A; Harral JW; Hyen Baek J; Pak D; Loomis Z; Hassell D; Eigenberger P; Nozik-Grayck E; Nuss R; Hassell K; Stenmark KR; Buehler PW; Irwin DC
    J Physiol; 2019 Feb; 597(4):1073-1085. PubMed ID: 29931797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peroxisome Proliferator-Activated Receptor γ Regulates the V-Ets Avian Erythroblastosis Virus E26 Oncogene Homolog 1/microRNA-27a Axis to Reduce Endothelin-1 and Endothelial Dysfunction in the Sickle Cell Mouse Lung.
    Kang BY; Park K; Kleinhenz JM; Murphy TC; Sutliff RL; Archer D; Hart CM
    Am J Respir Cell Mol Biol; 2017 Jan; 56(1):131-144. PubMed ID: 27612006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sickle Cell Anemia Mediates Carotid Artery Expansive Remodeling That Can Be Prevented by Inhibition of JNK (c-Jun N-Terminal Kinase).
    Song H; Keegan PM; Anbazhakan S; Rivera CP; Feng Y; Omojola VO; Clark AA; Cai S; Selma J; Gleason RL; Botchwey EA; Huo Y; Tan W; Platt MO
    Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1220-1230. PubMed ID: 32160775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GSNOR and ALDH2 alleviate traumatic spinal cord injury.
    Khan M; Qiao F; Islam SMT; Dhammu TS; Kumar P; Won J; Singh AK; Singh I
    Brain Res; 2021 May; 1758():147335. PubMed ID: 33545099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Augmentation of S-Nitrosoglutathione Controls Cigarette Smoke-Induced Inflammatory-Oxidative Stress and Chronic Obstructive Pulmonary Disease-Emphysema Pathogenesis by Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function.
    Bodas M; Silverberg D; Walworth K; Brucia K; Vij N
    Antioxid Redox Signal; 2017 Sep; 27(7):433-451. PubMed ID: 28006950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy.
    Barnett SD; Buxton ILO
    Crit Rev Biochem Mol Biol; 2017 Jun; 52(3):340-354. PubMed ID: 28393572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inflammatory profiles of pulmonary alveolar macrophages and alveolar type 2 cells in SCD.
    Gbotosho OT; Li W; Joiner CH; Brown LAS; Hyacinth HI
    Exp Biol Med (Maywood); 2023 Jun; 248(12):1013-1023. PubMed ID: 37012678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propofol Protects Lung Endothelial Barrier Function by Suppression of High-Mobility Group Box 1 (HMGB1) Release and Mitochondrial Oxidative Damage Catalyzed by HMGB1.
    Feng Z; Wang JW; Wang Y; Dong WW; Xu ZF
    Med Sci Monit; 2019 May; 25():3199-3211. PubMed ID: 31040263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.
    Sun X; Qiu J; Strong SA; Green LS; Wasley JW; Colagiovanni DB; Mutka SC; Blonder JP; Stout AM; Richards JP; Chun L; Rosenthal GJ
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3671-5. PubMed ID: 21570838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial TLR4 Expression Mediates Vaso-Occlusive Crisis in Sickle Cell Disease.
    Beckman JD; Abdullah F; Chen C; Kirchner R; Rivera-Rodriguez D; Kiser ZM; Nguyen A; Zhang P; Nguyen J; Hebbel RP; Belcher JD; Vercellotti GM
    Front Immunol; 2020; 11():613278. PubMed ID: 33542720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a Novel Inhibitor of Human Rhinovirus Replication and Inflammation in Airway Epithelial Cells.
    Yang Z; Bochkov YA; Voelker DR; Foster MW; Que LG
    Am J Respir Cell Mol Biol; 2019 Jan; 60(1):58-67. PubMed ID: 30156431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma levels of E-selectin are associated with retinopathy in sickle cell disease.
    Agouti I; Masson E; Loundou A; Jean E; Arnaud L; Abdili E; Berenger P; Lavoipierre V; Séguier J; Dignat-George F; Lacroix R; Bernit E
    Eur J Haematol; 2023 Mar; 110(3):271-279. PubMed ID: 36409296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular pathophysiology of sickle cell disease.
    Connes P; Renoux C; Joly P; Nader E
    Presse Med; 2023 Dec; 52(4):104202. PubMed ID: 37944640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-mobility group box 1 increases platelet surface P2Y12 and platelet activation in sickle cell disease.
    Nolfi-Donegan D; Annarapu GK; St Croix C; Calderon M; Hillery CA; Shiva S
    JCI Insight; 2024 Mar; 9(5):. PubMed ID: 38456510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice.
    Arumugam PI; Mullins ES; Shanmukhappa SK; Monia BP; Loberg A; Shaw MA; Rizvi T; Wansapura J; Degen JL; Malik P
    Blood; 2015 Oct; 126(15):1844-55. PubMed ID: 26286849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatty acid nitroalkenes - Multi-target agents for the treatment of sickle cell disease.
    Chowdhury FA; Colussi N; Sharma M; Wood KC; Xu JZ; Freeman BA; Schopfer FJ; Straub AC
    Redox Biol; 2023 Dec; 68():102941. PubMed ID: 37907055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacies of S-nitrosoglutathione (GSNO) and GSNO reductase inhibitor in SARS-CoV-2 spike protein induced acute lung disease in mice.
    Kim J; Qiao F; Singh AK; Won J; Singh I
    Front Pharmacol; 2023; 14():1304697. PubMed ID: 38143504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.